Additionally, the secretion of immune-suppressive cytokines such as TGF-β, IL-10, and IL-6 actively inhibits CAR T cell expansion and persistence, reducing long-term survival of therapeutic T cells at the tumor site (86, 95, 96). Here, TGFB1 is linked to neoplasm.